These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

772 related items for PubMed ID: 8576667

  • 1. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
    Scheen AJ.
    Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J, Soszyński P.
    Przegl Lek; 1999 Sep; 56(5):335-41. PubMed ID: 10554569
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of acarbose as monotherapy in NIDDM patients.
    Deerochanawong C, Serirat S, Kornthong P.
    J Med Assoc Thai; 1996 Feb; 79(2):69-75. PubMed ID: 8868016
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR.
    Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
    [Abstract] [Full Text] [Related]

  • 9. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
    Graham JP, Stam D.
    Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R, Johnson DG.
    Arch Intern Med; 1997 Apr 28; 157(8):836-48. PubMed ID: 9129543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose].
    Gentile S, Turco S, Guarino G, Oliviero B, Rustici A, Torella R.
    Ann Ital Med Int; 1999 Apr 28; 14(1):7-14. PubMed ID: 10528419
    [Abstract] [Full Text] [Related]

  • 16. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J, Czupryniak L.
    Med Sci Monit; 2003 Jun 28; 9(6):CR240-3. PubMed ID: 12824953
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun 28; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

  • 19. Type 2 diabetes: glycemic targets and oral therapies for older patients.
    Lardinois CK.
    Geriatrics; 1998 Nov 28; 53(11):22-3, 27-8, 33-4 passim. PubMed ID: 9824974
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL, Wolf SL, Kabadi UM.
    Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.